The Effect of Virtual-Reality-Based Exposure Training for Panic Disorder and Agoraphobia: A Pilot Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0007996

Enrollment

Registered

2022-12-12

Start date

2022-07-25

Completion date

Unknown

Last updated

2023-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : - General VR exposure (n = 25): The traditional (as usual) VR treatment program. All participants will be exposed to the same VR scenario. The environment will be randomized for all par

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Inclusion criteria A) 18-64 years old B) Diagnosed as panic disorder (E) or agoraphobia (F) in the Mini-International Neuropsychiatric Interview (MINI) C) Be able to understand the content of the consent form and have verbal and cognitive abilities enough to respond to the questionnaires and operate the VR devices/programs D) Can fully understand the detailed explanation regarding this study and voluntarily agree to participate in this study

Exclusion criteria

Exclusion criteria: (2) Exclusion criteria A) Moderate or higher suicidal tendencies (C), current manic (not hypomanic) episode (D), current/lifetime psychotic disorder or mood disorder with psychotic features (L), or antisocial personality disorder (P) are diagnosed in MINI B) Have ever been diagnosed with psychotic disorder or severe bipolar disorder C) Suicide attempt within the last 6 months D) Epileptic or photosensitivity seizures or have a history of such seizures E) Visual impairment (other than correctable refractive error or color vision impairment) F) Moderate to severe hearing loss G) Difficulty in operating the VR program due to problems with voluntary movement H) Serious clinical problems in the cardiovascular system, digestive system, respiratory system, endocrine system, or central nervous system that make it difficult to participate in the study I) Pregnant or lactating women J) Others judged unsuitable for this study by the PI or researcher(s)

Design outcomes

Primary

Measure	Time frame
Panic Disorder Severity Scale	—

Secondary

Measure	Time frame
Albany Panic-Phobia Questionnaire;Body Sensation Questionnaire;State-Trait Anxiety Inventory;Center for Epidemiologic Studies Depression Scale;Pittsburgh Sleep Quality Index;Heart Rate Variability;Electroencephalogram;Functional Near-Infrared Spectroscopy;Visual Analogue Scale for Anxiety;VR Presence/Fatigue	—

Countries

Korea, Republic of

Contacts

Public ContactHan Jung

Hallym University Medical Center- Chuncheon

jhw2@naver.com+82-33-240-5739

Outcome results